Jasper Therapeutics, Inc. (JSPR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -14.55M | -21.87M | -17M | -15.45M | -22.84M | -21.13M | -14.05M | -11.68M | -15.74M | -16.48M | -11.98M | -13.27M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 36.31% | -3.47% | -20.97% | -32.3% | -45.16% | -28.25% | -17.29% | 12% | -52.26% | -30.31% | -24.25% | -41.86% |
| Net Income | -1.17M | -9.1M | -18.74M | -26.72M | -21.24M | -24.32M | -18.64M | -14.58M | -13.73M | -16.58M | -17.54M | -16.08M |
| Depreciation & Amortization | 21K | 290K | 229K | 258K | 279K | 245K | 541K | 299K | 288K | 283K | 276K | 377K |
| Stock-Based Compensation | 0 | 1.66M | 1.42M | 1.82M | 1.81M | 1.97M | 0 | 1.48M | 1.17M | 1.16M | 1.4M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -831K | 0 | 0 |
| Other Non-Cash Items | -9.03M | -4.99M | 271K | 317K | 193K | 141K | 2.1M | 120K | 136K | 915K | -228K | 971K |
| Working Capital Changes | -4.36M | -9.73M | -187K | 8.88M | -3.88M | 831K | 1.94M | 1M | -3.6M | -1.42M | 4.12M | 1.46M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -663K | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -283K | 0 | 0 |
| Change in Payables | -3.78M | -2.95M | 1.13M | 5.05M | -1.04M | 957K | 222K | 457K | -1.76M | 893K | 1.68M | -2.27M |
| Cash from Investing | 0 | 0 | 0 | 1K | 4K | -76K | -274K | -157K | -25K | -230K | 0 | -11K |
| Capital Expenditures | 0 | 0 | 0 | -7K | 0 | -96K | -274K | -157K | -25K | -230K | 0 | -11K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 20K | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 8K | 4K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | -340K | 28.39M | 6.16M | 0 | 345K | 9K | 181K | 47.35M | -271K | 36K | -305K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | -340K | 514K | 5.94M | 0 | 345K | 9K | 181K | 47.2M | 28K | 36K | 356K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 27.87M | 223K | 0 | 0 | 0 | 0 | 154K | -299K | 0 | -661K |
| Net Change in Cash | -14.55M | -22.21M | 11.39M | -9.29M | -22.84M | -20.86M | -14.32M | -11.66M | 31.59M | -16.98M | -11.95M | -13.59M |
| Free Cash Flow | -14.55M | -21.87M | -17M | -15.46M | -22.84M | -21.23M | -14.33M | -11.84M | -15.76M | -16.71M | -11.98M | -13.28M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 36.31% | -3% | -18.66% | -30.61% | -44.93% | -27.06% | -19.57% | 10.89% | -52.12% | -31.28% | -21.45% | -38.38% |
| FCF per Share | -0.95 | -1.43 | -1.02 | -1.01 | -1.52 | -1.41 | -0.96 | -0.79 | -1.18 | -1.51 | -1.09 | -1.22 |
| FCF Conversion (FCF/Net Income) | 12.39x | 2.40x | 0.91x | 0.58x | 1.08x | 0.87x | 0.75x | 0.80x | 1.15x | 0.99x | 0.68x | 0.83x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |